Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pycnogenol® in People With Post-COVID-19 Condition: a Quadruple-blind, Randomized, Placebo-controlled Trial

NCT05890534 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT05890534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pycnogenol® in People With Post-COVID-19 Condition: a Quadruple-blind, Randomized, Placebo-controlled Trial
Lead sponsor
University of Zurich
Phase
Phase 3
Overall status
Completed
Start date
June 7, 2023
Completion date
January 31, 2025
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, post covid-19 condition